ALMR
Income statement / Annual
Last year (2025), Alamar Biosciences Inc.'s total revenue was $74.21 M,
and the percentage change from the previous year is not available.
In 2025, Alamar Biosciences Inc.'s net income was -$29.82 M.
See Alamar Biosciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
| Period Ended |
12/31/2025 |
| Operating Revenue |
$74.21 M |
| Cost of Revenue |
$32.51 M
|
| Gross Profit |
$41.71 M
|
| Gross Profit Ratio |
0.56
|
| Research and Development Expenses |
$37.47 M
|
| General & Administrative Expenses |
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
| Selling, General & Administrative Expenses |
$35.57 M
|
| Other Expenses |
$0.00
|
| Operating Expenses |
$73.04 M
|
| Cost And Expenses |
$105.55 M
|
| Interest Income |
$2.16 M
|
| Interest Expense |
$401.00 K
|
| Depreciation & Amortization |
$3.86 M
|
| EBITDA |
-$24.89 M |
| EBITDA Ratio |
-0.34
|
| Operating Income Ratio |
-0.42
|
| Total Other Income/Expenses Net |
$2.18 M
|
| Income Before Tax |
-$29.15 M
|
| Income Before Tax Ratio |
-0.39
|
| Income Tax Expense |
$665.00 K
|
| Net Income |
-$29.82 M
|
| Net Income Ratio |
-0.4
|
| EPS |
-0.45 |
| EPS Diluted |
-0.45 |
| Weighted Average Shares Out |
$66.52 M
|
| Weighted Average Shares Out Diluted |
$66.52 M
|
| Link |
|
